BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20507312)

  • 1. All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.
    Singh AT; Evens AM; Anderson RJ; Beckstead JA; Sankar N; Sassano A; Bhalla S; Yang S; Platanias LC; Forte TM; Ryan RO; Gordon LI
    Br J Haematol; 2010 Jul; 150(2):158-69. PubMed ID: 20507312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Nanoscale Delivery Particles Encapsulated with Anticancer Drugs, All-trans Retinoic Acid or Curcumin, Enhance Apoptosis in Lymphoma Cells Predominantly Expressing CD20 Antigen.
    Stauffer RG; Mohammad M; Singh AT
    Anticancer Res; 2015 Dec; 35(12):6425-9. PubMed ID: 26637852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curcumin nanodisk-induced apoptosis in mantle cell lymphoma.
    Singh AT; Ghosh M; Forte TM; Ryan RO; Gordon LI
    Leuk Lymphoma; 2011 Aug; 52(8):1537-43. PubMed ID: 21699455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid-mediated inhibition of cell growth with stimulation of apoptosis in aggressive B-cell lymphomas.
    Sundaresan A; Claypool K; Mehta K; Lopez-Berestein G; Cabanillas F; Ford RJ
    Cell Growth Differ; 1997 Oct; 8(10):1071-82. PubMed ID: 9342185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells.
    Darwiche N; El-Sabban M; Bazzi R; Nasr R; Al-Hashimi S; Hermine O; de Thé H; Bazarbachi A
    Hematol J; 2001; 2(2):127-35. PubMed ID: 11424005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-302b-inhibited E2F3 transcription factor is related to all trans retinoic acid-induced glioma cell apoptosis.
    Chen PH; Shih CM; Chang WC; Cheng CH; Lin CW; Ho KH; Su PC; Chen KC
    J Neurochem; 2014 Dec; 131(6):731-42. PubMed ID: 25040912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of Calu-1 human lung carcinoma cell growth in serum-free medium by retinoids: dependence on AP-1 activation, but not on retinoid response element activation.
    Wan H; Dawson MI; Hong WK; Lotan R
    Oncogene; 1997 Oct; 15(17):2109-18. PubMed ID: 9366527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
    Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
    Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment of P-gp-positive L1210/VCR cells by verapamil and all-trans retinoic acid induces down-regulation of P-glycoprotein expression and transport activity.
    Sulová Z; Macejová D; Seres M; Sedlák J; Brtko J; Breier A
    Toxicol In Vitro; 2008 Feb; 22(1):96-105. PubMed ID: 17920233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinol inhibits the growth of all-trans-retinoic acid-sensitive and all-trans-retinoic acid-resistant colon cancer cells through a retinoic acid receptor-independent mechanism.
    Park EY; Dillard A; Williams EA; Wilder ET; Pepper MR; Lane MA
    Cancer Res; 2005 Nov; 65(21):9923-33. PubMed ID: 16267017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
    Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
    Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid stimulates the cell cycle machinery in normal T cells: involvement of retinoic acid receptor-mediated IL-2 secretion.
    Ertesvag A; Engedal N; Naderi S; Blomhoff HK
    J Immunol; 2002 Nov; 169(10):5555-63. PubMed ID: 12421932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of all-trans-retinoic acid on enterovirus 71 infection in vitro.
    Chen S; Yang Y; Xu J; Su L; Wang W
    Br J Nutr; 2014 May; 111(9):1586-93. PubMed ID: 24495389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect pathway of retinoic acid through regulation of retinoic acid receptor alpha in gastric cancer cells.
    Liu S; Wu Q; Chen ZM; Su WJ
    World J Gastroenterol; 2001 Oct; 7(5):662-6. PubMed ID: 11819850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen.
    Mehta K; McQueen T; Manshouri T; Andreeff M; Collins S; Albitar M
    Blood; 1997 May; 89(10):3607-14. PubMed ID: 9160665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest.
    Yang L; Ostrowski J; Reczek P; Brown P
    Oncogene; 2001 Nov; 20(55):8025-35. PubMed ID: 11753686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: implications for in vivo retinoic acid use.
    Giannini F; Maestro R; Vukosavljevic T; Pomponi F; Boiocchi M
    Int J Cancer; 1997 Jan; 70(2):194-200. PubMed ID: 9009160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RARγ-C-Fos-PPARγ2 signaling rather than ROS generation is critical for all-trans retinoic acid-inhibited adipocyte differentiation.
    Wang X; Yang P; Liu J; Wu H; Yu W; Zhang T; Fu H; Liu Y; Hai C
    Biochimie; 2014 Nov; 106():121-30. PubMed ID: 25173565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumoral activity of 13-demethyl or 13-substituted analogues of all-trans retinoic acid and 9-cis retinoic acid in the human myeloid leukemia cell line HL-60.
    Mizuguchi Y; Wada A; Nakagawa K; Ito M; Okano T
    Biol Pharm Bull; 2006 Sep; 29(9):1803-9. PubMed ID: 16946489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.
    Paroni G; Fratelli M; Gardini G; Bassano C; Flora M; Zanetti A; Guarnaccia V; Ubezio P; Centritto F; Terao M; Garattini E
    Oncogene; 2012 Jul; 31(29):3431-43. PubMed ID: 22056878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.